Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy-Reference-Cited by-同舟云学术

Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy

Published:2012 Issue:5 Volume:82 Page:298-304
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Kimura Tetsuo,Okamoto Koichi,Miyamoto Hiroshi,Kimura Masako,Kitamura Shinji,Takenaka Hidetaka,Muguruma Naoki,Okahisa Toshiya,Aoyagi Eriko,Kajimoto Mayumi,Tsuji Yasushi,Kogawa Takahiro,Tsuji Akihito,Takayama Tetsuji

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference20 articles.

1. Cetuximab for the Treatment of Colorectal Cancer

2. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

3. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

4. K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

5. Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PNA Clamping in Nucleic Acid Amplification Protocols to Detect Single Nucleotide Mutations Related to Cancer;Molecules;2020-02-12

2. Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach;Molecular Diagnosis & Therapy;2019-07-25

3. Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR;Scientific Reports;2019-06-04

4. Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices;Expert Review of Molecular Diagnostics;2018-04-26

5. Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers;Scientific Reports;2017-10-23